Amgen (AMGN)
Frequently Asked Questions About Amgen (AMGN)
Does Amgen have a global presence?
Yes, Amgen has a global presence with operations in numerous countries, which allows it to reach patients and healthcare providers worldwide, thereby maximizing the impact of its medicines.
How can I find more information about Amgen?
More information about Amgen can be found on its official website, where you can access details about its products, research initiatives, financial reports, and ongoing commitments to patients and healthcare.
How can I invest in Amgen?
Investors can buy shares of Amgen on the Nasdaq stock exchange under the ticker symbol AMGN. It is advisable for potential investors to conduct thorough research or consult with financial advisors before investing.
How does Amgen contribute to healthcare?
Amgen contributes to healthcare by developing innovative therapies that address unmet medical needs, improving patient outcomes, and enhancing the quality of life for those with serious diseases.
How does Amgen ensure the quality of its products?
Amgen ensures the quality of its products through rigorous quality control processes, validations at every stage of manufacturing, and compliance with global regulatory standards to safeguard patient safety.
How does Amgen support patients?
Amgen supports patients through various programs, including patient assistance initiatives, educational resources, and partnerships with healthcare professionals to ensure that patients have access to the information and treatments they need.
How many employees does Amgen have?
As of 2023, Amgen employs approximately 25,000 people worldwide, including scientists, healthcare professionals, and support staff, all dedicated to advancing the company's mission.
Is Amgen involved in any partnerships?
Yes, Amgen frequently engages in partnerships with academic institutions, biotechnology companies, and pharmaceutical firms to foster innovation, share expertise, and accelerate the development of new therapies.
What are some key products developed by Amgen?
Amgen has developed several key products, including Epoetin alfa (Epogen), an anemia treatment; Filgrastim (Neupogen), which stimulates the production of white blood cells; and Otezla, a treatment for psoriasis and psoriatic arthritis.
What are some recent developments or news about Amgen?
Recently, Amgen has focused on expanding its pipeline of innovative therapies, advancing clinical trials, and seeking regulatory approvals for new drugs in key therapeutic areas, highlighting its commitment to innovation.
What does Amgen do?
Amgen is a biopharmaceutical company that focuses on developing and manufacturing innovative therapies to treat serious illnesses. The company's products primarily target diseases in areas such as oncology, cardiovascular disease, immunology, and bone health.
What is Amgen's approach to research and development?
Amgen's approach to research and development is characterized by a focus on innovative science aimed at understanding disease mechanisms, leveraging advanced biotechnology, and collaborating with partners to bring new therapies to market.
What is Amgen's commitment to sustainability?
Amgen is committed to sustainability through various initiatives aimed at reducing its environmental impact, including energy efficiency, waste reduction, and sustainable sourcing across its operations.
What is Amgen's dividend policy?
Amgen has a history of paying dividends to shareholders and typically reviews its dividend policy regularly to align with its financial performance while balancing the need for investments in research and development.
What is Amgen's mission statement?
Amgen's mission is to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives, reflecting its commitment to innovation and patient care.
What is Amgen's role in biomanufacturing?
Amgen plays a significant role in biomanufacturing by employing advanced bioprocessing technologies to produce high-quality biologics at scale, ensuring that its innovative therapies can be efficiently delivered to patients.
What is the significance of Amgen’s research collaborations?
Amgen's research collaborations are significant because they leverage diverse expertise and resources to drive innovation, accelerate drug development, and enhance the potential to bring new life-saving therapies to market.
What therapeutic areas does Amgen focus on?
Amgen focuses on several therapeutic areas, including oncology (cancer treatment), cardiovascular disease, bone health, nephrology (kidney), and immunology, developing targeted therapies for each of these areas.
When was Amgen founded?
Amgen was founded in 1980 in Thousand Oaks, California. The company started as a biotechnology pioneer and has grown into one of the world's leading independent biotechnology companies.
Where is Amgen headquartered?
Amgen is headquartered in Thousand Oaks, California, where it operates a state-of-the-art campus that includes research, development, and manufacturing facilities.
What is the current price of Amgen?
The current price of Amgen is 309.85
When was Amgen last traded?
The last trade of Amgen was at 4:00 pm EDT on April 3rd, 2025